ABOUT DR GALM

Dr Galm is an endocrinologist at Vancouver General Hospital and clinical assistant professor at the University of British Columbia.

He has a particular interest in pituitary disorders, including prolactinomas, Cushing's syndrome, acromegaly, and other pituitary problems. He spent two years working with several world experts in pituitary disease at the Neuroendocrine Unit at Massachusetts General Hospital in Boston.

However, he sees patients with all sorts of endocrine disorders, including diabetes, osteoporosis, and diseases of the thyroid, adrenals, and female and male reproductive systems. He also sees transgender individuals.

He is also actively involved in teaching. He teaches several diabetes courses for the UBC medical students, endocrine topics for the internal medicine residents, and subspecialty endocrinology for the endocrine fellows. He also regularly has residents and fellows in clinic with him.

EDUCATION

BACHELOR OF SCIENCE (BSC)

University of British Columbia

Pharmacology & Therapeutics

MEDICAL DEGREE (MD)

University of British Columbia

Doctor of Medicine

INTERNAL MEDICINE RESIDENCY

University of Alberta Hospital

Internal Medicine

ENDOCRINOLOGY FELLOWSHIP

University of Alberta Hospital

Endocrinology & Metabolism

MASTER OF PUBLIC HEALTH (MPH)

Harvard School of Public Health

Quantitative Methods & Epidemiology

PITUITARY FELLOWSHIP

Massachusetts General Hospital

Pituitary Research & Clinical Fellowship

PUBLICATIONS

ACCURACY OF LABORATORY TESTS FOR THE DIAGNOSIS OF CUSHING SYNDROME

Galm BP, Qiao N, Klibanski A, Biller BMK, Tritos NA.

Journal of Clinical Endocrinology & Metabolism 2020 Jun;105(6):dgaa105. doi: 10.1210/clinem/dgaa105

MRI TEXTURE ANALYSIS IN ACROMEGALY AND ITS ROLE IN PREDICTING RESPONSE TO SOMATOSTATIN RECEPTOR LIGANDS

Galm BP, Buckless C, Swearingen B, Torriani M, Klibanski A, Bredela MA, Tritos NA

Pituitary 2020 Jun;23(3):212–222. doi: 10.1007/s11102-019-01023-0

ACUTE MANAGEMENT OF DIABETIC KETOACIDOSIS IN ADULTS AT THREE TEACHING HOSPITALS IN CANADA: A MULTI-CENTRE, RETROSPECTIVE COHORT STUDY

Galm BP, Bagshaw SM, Senior PA

Canadian Journal of Diabetes 2019 Jul;43(5):309–315. doi: 10.1016/j.jcjd.2018.11.003

MRI TEXTURE ANALYSIS AS A PREDICTOR OF TUMOR RECURRENCE OR PROGRESSION IN PATIENTS WITH CLINICALLY NON-FUNCTIONING PITUITARY ADENOMAS

Galm BP, Martinez-Salazar EL, Swearingen B, Torriani M, Klibanski A, Bredela MA, Tritos NA

European Journal of Endocrinology 2018 Sep; 179(3): 191–198. doi: 10.1530/EJE-18-0291

0.9% SALINE OR BALANCED CRYSTALLOID FLUIDS FOR CRITICALLY ILL PATIENTS: SPLIT DECISION?

Galm B, Bagshaw SM

American Journal of Kidney Diseases 2016; 68(1): 11–14

BLOOD PRESSURE LOWERING EFFICACY OF ALPHA BLOCKERS FOR PRIMARY HYPERTENSION

Heran BS, Galm BP, Wright JM

Cochrane Database Systematic Reviews 2012: CD004643

EVIDENCE-BASED MEDICINE: AN INTRODUCTION FOR MEDICAL STUDENTS

Diao D, Galm B, Shamon S

UBC Medical Journal 2009; 1(1): 16–18

BOOK CHAPTERS

CUSHING'S SYNDROME

Handbook of Inpatient Endocrinology

Galm BP, Tritos NA

MITOCHONDRIAL DIABETES: M.3243A>G MUTATION

Atypical Diabetes: Pathophysiology, Clinical Presentations, and Treatment Options

Galm BP, Sirrs S, Yeung RO